Options Brief: Repros Therapeutics (RPRX)

Shares of Repros Therapeutics RPRX are higher on the session by 9.36%, trading at $6.33. Overall call volume is now running at 10.49x the daily average, with 66% of all calls traded being purchases on the offer. 1,427 contracts have traded on the session so far. Repros Therapeutics Inc. is a development-stage biopharmaceutical company focused on the development of oral small molecule drugs for unmet medical needs.